Mor Research Applications is the Technology Transfer Office of Clalit Health Services, the largest HMO in Israel, providing end-to-end technology transfer services. MOR helps inventors translate new ideas in the medical, pharmaceutical, diagnostics, medical IT, and biotechnology areas into products and solutions that benefit healthcare providers and patients.
MOR’s commercialization portfolio comprises over 100 different projects and companies at various stages of development, from pre-seed to advanced stage companies. The intellectual property is conceived and developed by professionals working at all fourteen hospitals owned by Clalit, and around 2,000 clinics across the country, including the Rabin, Meir, Kaplan, Carmel, Soroka, Ha-Emek, and Schneider medical centers. MOR draws on over two decades of experience to ensure that the process of commercialization of these inventions yields gains for the researchers, industry partners, and the public at large. The main role of MOR Research Application is to capture innovation through its invention disclosure process, evaluate whether the invention has market and patent protection value, secure patent protection, secure licensing agreements or establish spin-offs for further development. In addition to the IP department, MOR serves Clalit’s employees through its research fund division, which currently handles over one thousand funds for Clalit doctors and researchers.
Mor was founded in 1994 as a subsidiary of The Mor Institute and a holding of Clalit Health Services.